Clinical Trials Directory

Trials / Unknown

UnknownNCT04990492

Interactive Voice Based Administration of the GAD 7

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Oklahoma State University Center for Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study investigates a new delivery method for the General Anxiety Disorder - 7 (GAD 7), a clinically accepted tool for diagnosing general anxiety disorder. The new tool records auditory responses to the assessment and the study will examine if the instrument is effective at capturing participant depression levels. If proven effective, future studies may investigate if the new format can be used to improve at home clinical care.

Detailed description

This study is an investigation of the construct validity and user experience of a new delivery system for the General Anxiety Disorder - 7 (GAD 7), a clinically accepted tool for diagnosing general anxiety disorder. The purpose of the study is to examine if the new delivery system of the GAD 7 is effective at capturing participant anxiety levels and to assess the differences of usability between the paper and voice administered versions. The voice administered version uses a Mirror device, which is similar to a smart television with a mirror interface. The device records auditory responses to the GAD 7 through Amazon Alexa. The investigators will be comparing the responses on the new device to those given on the clinically established paper format. If proven effective at capturing depression levels of patients, future studies may investigate if the new format can be used to improve at home clinical care.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPaper GAD 7The paper based GAD 7 that is commonly accepted at clinics
DIAGNOSTIC_TESTVoice Administered GAD 7This is the voice based GAD 7 that is administered through a Mirror device equipped with Amazon Alexa software.

Timeline

Start date
2021-06-10
Primary completion
2022-05-31
Completion
2022-06-15
First posted
2021-08-04
Last updated
2022-04-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04990492. Inclusion in this directory is not an endorsement.